Clinical Trial Update: SYMPLICITY HTN-3 Renal Denervation in Patients With Uncontrolled Hypertension [NA]

View source ↗

Summary

This update reports the completed status of the SYMPLICITY HTN-3 trial evaluating renal denervation in patients with hypertension. No efficacy results are provi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Snippet

Sponsor: Medtronic Vascular | Conditions: Uncontrolled Hypertension | NA | Status: COMPLETED